SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-22-000034
Filing Date
2022-11-08
Accepted
2022-11-08 16:31:31
Documents
55
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20221108.htm   iXBRL 8-K 32667
2 EX-99.1 exhibit991-q0322.htm EX-99.1 101804
3 EX-99.2 rxrx2022q3websitefinal.htm EX-99.2 45140
7 pipelinegraphic.jpg GRAPHIC 155173
8 rxrx2022q3websitefinal001.jpg GRAPHIC 63020
9 rxrx2022q3websitefinal002.jpg GRAPHIC 224148
10 rxrx2022q3websitefinal003.jpg GRAPHIC 86511
11 rxrx2022q3websitefinal004.jpg GRAPHIC 106994
12 rxrx2022q3websitefinal005.jpg GRAPHIC 109819
13 rxrx2022q3websitefinal006.jpg GRAPHIC 133749
14 rxrx2022q3websitefinal007.jpg GRAPHIC 221242
15 rxrx2022q3websitefinal008.jpg GRAPHIC 73354
16 rxrx2022q3websitefinal009.jpg GRAPHIC 104033
17 rxrx2022q3websitefinal010.jpg GRAPHIC 93979
18 rxrx2022q3websitefinal011.jpg GRAPHIC 109888
19 rxrx2022q3websitefinal012.jpg GRAPHIC 84933
20 rxrx2022q3websitefinal013.jpg GRAPHIC 116447
21 rxrx2022q3websitefinal014.jpg GRAPHIC 120725
22 rxrx2022q3websitefinal015.jpg GRAPHIC 134254
23 rxrx2022q3websitefinal016.jpg GRAPHIC 121325
24 rxrx2022q3websitefinal017.jpg GRAPHIC 140299
25 rxrx2022q3websitefinal018.jpg GRAPHIC 113116
26 rxrx2022q3websitefinal019.jpg GRAPHIC 105192
27 rxrx2022q3websitefinal020.jpg GRAPHIC 114404
28 rxrx2022q3websitefinal021.jpg GRAPHIC 115681
29 rxrx2022q3websitefinal022.jpg GRAPHIC 108153
30 rxrx2022q3websitefinal023.jpg GRAPHIC 118470
31 rxrx2022q3websitefinal024.jpg GRAPHIC 140508
32 rxrx2022q3websitefinal025.jpg GRAPHIC 106132
33 rxrx2022q3websitefinal026.jpg GRAPHIC 125856
34 rxrx2022q3websitefinal027.jpg GRAPHIC 135743
35 rxrx2022q3websitefinal028.jpg GRAPHIC 120754
36 rxrx2022q3websitefinal029.jpg GRAPHIC 108811
37 rxrx2022q3websitefinal030.jpg GRAPHIC 133839
38 rxrx2022q3websitefinal031.jpg GRAPHIC 113597
39 rxrx2022q3websitefinal032.jpg GRAPHIC 132191
40 rxrx2022q3websitefinal033.jpg GRAPHIC 103373
41 rxrx2022q3websitefinal034.jpg GRAPHIC 108478
42 rxrx2022q3websitefinal035.jpg GRAPHIC 94955
43 rxrx2022q3websitefinal036.jpg GRAPHIC 132619
44 rxrx2022q3websitefinal037.jpg GRAPHIC 71595
45 rxrx2022q3websitefinal038.jpg GRAPHIC 120325
46 rxrx2022q3websitefinal039.jpg GRAPHIC 82607
47 rxrx2022q3websitefinal040.jpg GRAPHIC 108044
  Complete submission text file 0001601830-22-000034.txt   6983789

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20221108.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20221108_lab.xml EX-101.LAB 24831
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20221108_pre.xml EX-101.PRE 13045
49 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20221108_htm.xml XML 11018
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 221369395
SIC: 2836 Biological Products, (No Diagnostic Substances)